European Association for Haematopathology 21st Meeting 2022
Format: 28 videos + 1 pdf, size: 20.8 GB
Course Audience: pathologist, hematologist
Overview:
few years, triggered by the new DNA sequencing technologies and other molecular techniques that allow us to investigate the pathogenesis of well-known diseases as well as to recognize new emerging entities. We, as pathologists, need to integrate this new information with our solid morphologic background, which continues to be the essence of our profession. These innovative technologies have clinical impact, prompting the development of new targeted drugs and better therapeutic strategies for our patients. To bridge the gap, we have prepared an exciting programme devoted to “Novel frontiers in molecular diagnosis of lymphoma and myeloid neoplasms: biomarkers and integrative prognostic models”.
The goal is to explore how best to integrate into our daily clinical practice the plethora of new technologies that help us understand lymphoma biology and myeloid neoplasms. The highlight of our meeting is the Karl Lennert’s lecture, with which the EAHP honors an outstanding haematopathologist/biologist for their inspiring contribution in advancing and shaping the understanding of our field. The 2022 Karl Lennert awardee is Prof. Philippe Gaulard, a very esteemed past president of our Society, who will share with us his long adventure “Understanding peripheral T-cell lymphomas – lesson from the past moving to the future”. It is also with great pleasure that I announce the David Y Mason lecture, which is dedicated to honor the innovative approach to science and spirit of David Y Mason, who once said, “each technological advance applied in Pathology opens a window to a new landscape of knowledge”. This year we welcome Teresa Palomero with the lecture on “Oncogenic mechanisms in the development of T-cell lymphomas”. I also want to thank the generous contribution of the David Y Mason foundation and Teresa Marafioti for the Mason ́s Award that is given to a young researcher to foster interest in hematopathology. An important part of our meeting is the EAHP educational session. For this meeting, we have prepared a special long session dedicated to cover the two proposals to update the lymphoma and myeloid classifications. There have been 4 recent publications presenting the two classifications; the International Consensus Classification (2022 ICC), published in Blood, and the 5th Edition WHO classification, published in Leukemia. Certainly, our members and in general the hematopathology community will have questions on how to handle the practical reality of navigating these two classifications in their daily diagnostic work. Although many entities are identical in the two classifications, there are significant differences in nomenclature and diagnostic criteria for others, and some disease entities are recognized in one but not in both classifications. The educational session will be dedicated to present both classifications and try to highlight and discuss the different approaches. The session includes one hour at the end of the presentations for questions, to help our members to develop a roadmap to navigate specific diagnostic settings.
EAHP-SH-Florence-2022_program_FINAL_print_web (PDF Format)
Sep 17 OPENING CEREMONY (Video MP4 Format)
Sep 17 ROUND TABLE DISCUSSION about the current proposals for the classification of hematological malignancies (Video MP4 Format)
Sep 17 THE INTERNATIONAL CONSENSUS CLASSIFICATION OF HAEMATOLOGICAL MALIGNANCY (Video MP4 Format)
Sep 17 WHO CLASSIFICATION OF HAEMATOLYMPHOID TUMOURS (Video MP4 Format)
Sep 18 BONE MARROW SYMPOSIUM (Video MP4 Format)
Sep 18 BONE MARROW WORKSHOP SESSION 1 EMERGING PROVISIONAL ENTITIES (Video MP4 Format)
Sep 18 BONE MARROW WORKSHOP SESSION 2 Myeloma immunosecretory diseases amyloidosis (Video MP4 Format)
Sep 18 BONE MARROW WORKSHOP SESSION 3 Unusual other neoplasms mainly involving the bone marrow (Video MP4 Format)
Sep 19 KARL LENNERT LECTURE Understanding peripheral T-cell lymphoma lessons from the past moving to the future (Video MP4 Format)
Sep 19 LYMPHOMA SYMPOSIUM SESSION I (Video MP4 Format)
Sep 19 LYMPHOMA SYMPOSIUM SESSION II (Video MP4 Format)
Sep 19 LYMPHOMA SYMPOSIUM SESSION III (Video MP4 Format)
Sep 19 SATELLITE SYMPOSIA NGS-based clinical assessment of B- and T-cell clonality and MRD determination (Video MP4 Format)
Sep 19 SATELLITE SYMPOSIA Understanding and Facing Challenges in CD123- expressing Hematologic Malignancies (Video MP4 Format)
Sep 20 LYMPHOMA SYMPOSIUM SESSION IV (Video MP4 Format)
Sep 20 LYMPHOMA SYMPOSIUM SESSION V (Video MP4 Format)
Sep 20 LYMPHOMA SYMPOSIUM SESSION VI (Video MP4 Format)
Sep 20 SATELLITE SYMPOSIA How to improve differential diagnosis of unexplained lymphadenopathies (Video MP4 Format)
Sep 20 SATELLITE SYMPOSIA Importance of NGS and microarray in the analysis of the Immune repertoire (Video MP4 Format)
Sep 21 LYMPHOMA SYMPOSIUM SESSION VII (Video MP4 Format)
Sep 21 LYMPHOMA WORKSHOP SESSION 1 (continued) (Video MP4 Format)
Sep 21 LYMPHOMA WORKSHOP SESSION 1 (Video MP4 Format)
Sep 21 LYMPHOMA WORKSHOP SESSION 2 (continued) (Video MP4 Format)
Sep 21 LYMPHOMA WORKSHOP SESSION 2 (Video MP4 Format)
Sep 22 Final Remark (Video MP4 Format)
Sep 22 LYMPHOMA WORKSHOP SESSION 3 (Video MP4 Format)
Sep 22 LYMPHOMA WORKSHOP SESSION 4 (Video MP4 Format)
Sep 22 LYMPHOMA WORKSHOP SESSION 5 (Video MP4 Format)